ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Takayasu.s arteritis"

  • Abstract Number: 0695 • ACR Convergence 2023

    Impact and Cardiovascular Outcomes of Large Vessel Vasculitis in Atrial Fibrillation Hospitalization: A Nationwide Inpatient Database Study

    Sabahat Usmani1, Yanint Raksadawan1, Amro Taha1, Harigopal Sandhyavenu1, Jalpan Patel1, Thatiana Schulze Goni1, Hafiz Muhammad Waqar Younas1 and Irisha Badu2, 1Weiss Memorial Hospital, Chicago, IL, 2Onslow Memorial Hospital, Jacksonville, FL

    Background/Purpose: Atrial fibrillation is the most commonly treated cardiac arrhythmia, associated with significant morbidity and mortality. Recent research is suggestive that autoimmunity and inflammation might…
  • Abstract Number: 1575 • ACR Convergence 2023

    Takayasu Arteritis Is Associated with Worse Fatigue Than Healthy Controls Which Persists over Time – A Longitudinal Cohort Study

    Darpan Radheshyam Thakare, Upendra Rathore, Kritika Singh, Vikas Agarwal and Durga P Misra, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

    Background/Purpose: Few studies have assessed patient-reported outcome measures in Takayasu arteritis (TAK), a rare large vessel vasculitis. We prospectively analysed fatigue and fibromyalgia in TAK…
  • Abstract Number: 0696 • ACR Convergence 2023

    Association of Large-vessel Vasculitis with Inflammatory Bowel Diseases: A European Case-control Study

    Francois Maillet1, Yann Nguyen2, Olivier Espitia3, Laurent Perard4, Carlo Salvarani5, Etienne Rivière6, Cécile-Audrey Durel7, Philippe GUILPAIN8, Luc Mouthon9, Anna Kernder10, Javier Loricera11, Pascal Cohen12, Isabelle Melki13, Claire De Moreuil14, Nicolas Limal15, Arsène Mekinian16, Nathalie Costedoat-Chalumeau17, Nathalie Morel12, Jonathan Boutemy18, Loic Raffray19, Jean-Sébastien Allain20, Valerie Devauchelle21, Isabelle Kone-Paut22, Marc Fabre23, Marie Durel24, Antoine Dossier25, Sébastien Abad26, Marcella Visentini27, Adrien Bigot28, Halil Yildiz29, Olivier Fain30, Maxime Samson31, Guillaume Gondran32, Vered Abitbol1 and Benjamin Terrier33, 1Cochin Hospital, Paris, France, 2Department of Internal Medicine, Hôpital Beaujon, AP-HP, Clichy, France., Montmorency, France, 3CHU de Nantes, Nantes, France, 4CH Saint Hoseph Saint Luc, Lyon, France, 5Azienda USL -IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy, 6CHU Bordeaux, Bordeaux, France, 7CHU Lyon, Lyon, France, 8University of Montpellier, Montpellier, France, 9Hopital Cochin - Paris University, Paris, France, 10HHU Düsseldorf, Düsseldorf, Germany, 11Hospital Universitario Marqués de Valdecilla, Santander, Spain, 12CHU Cochin, Paris, France, 13Hopital Robert Debré, Sérurier, France, 14CHU de Brest, Brest, France, 15AP-HP, Créteil, France, 16Department of Internal Medicine, Hôpital Saint-Antoine, AP-HP, Paris, France, 17Inserm DR Paris 5, Paris, France, 18CHU de Caen, Caen, France, 19CHU la Réunion, La Réunion, France, 20CHU Rennes, Rennes, France, 21UBO, Brest, France, 22Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAIA, Bicêtre Hospital, APHP, University of Paris Saclay, Paris, France, 23CH Bourgoin-Jallieu, Bourgoin-Jallieu, France, 24CH Metz, Metz, France, 25AP-HP, Paris, France, 26Avicenne Hospital, Bobigny, France, 27Rome Hospital, Rome, France, 28Tours Hospital, Tours, France, 29Saint Luc Hospital, Bruxelles, Belgium, 30Hopital SAINT ANTOINE APHP, Paris, France, 31Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, 32Limoges Hospital, Limoges, France, 33Department of Internal Medicine, Hôpital Cochin, AP-HP, Paris, France

    Background/Purpose: The association of large vessel vasculitis (LVV), whether Takayasu arteritis (TA) or giant cell arteritis (GCA), with inflammatory bowel disease (IBD) is a rare…
  • Abstract Number: 1576 • ACR Convergence 2023

    Application of the 2022 ACR/EULAR Criteria for Takayasu Arteritis to Previously Diagnosed Patients Based on the 1990 ACR Criteria

    Jang Woo Ha1, Sung Soo Ahn2, Jason Jungsik Song2, Yong-Beom Park2 and Sang-Won Lee3, 1Yonsei University College of Medicine, Seodaemun-gu, Seoul, South Korea, 2Yonsei University College of Medicine, Seoul, South Korea, 3Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose: Recently, a joint group of the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) proposed new criteria for…
  • Abstract Number: 0697 • ACR Convergence 2023

    Alterations in Composition and Function of Gut Microbiota in Patients with Large-Vessel Vasculitis

    Adam Mayer1, Weiming Hu2, Kyle Bittinger2, Rui Liang3, Naomi Amudala3, Shubhasree Banerjee3, Peter Merkel3 and Rennie Rhee3, 1University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The gut microbiome has a critical role in immune homeostasis and there is growing interest in understanding the relationship between the microbiome and autoimmunity.…
  • Abstract Number: 1577 • ACR Convergence 2023

    Analysis of Takayasu’s Arteritis as Risk Factor for Acute Coronary Syndrome

    Maria Romero Noboa1, Shilpa Arora1 and Augustine Manadan2, 1John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: Takayasu's arteritis (TAK) is an autoimmune disease that primarily affects the aorta and its major branches. It has an incidence of 1-3 per million…
  • Abstract Number: 0699 • ACR Convergence 2023

    T Cell Subset Analysis in Patients with Large-Vessel Vasculitis

    Rebecca Kuan1, Christopher Redmond1, McKella Sylvester2, Mary Maclean1, Francoise Meylan1, Marcela Ferrada1, Kaitlin Quinn1 and Peter Grayson3, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 2Colgate University, Bethesda, MD, 3National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Chevy Chase, MD

    Background/Purpose: Large-vessel vasculitis (LVV) is characterized by granulomatous inflammation of the aorta and its major branches. The two major forms are giant cell arteritis (GCA)…
  • Abstract Number: 1578 • ACR Convergence 2023

    Impact of Anxiety or Depression Status and Fibromyalgia on Adherence to Treatment of Patients with Takayasu Arteritis

    Alejandra Espinosa-Orantes1, David Vera-Bustamante2, Jessica Roldan Ortega3, Maria Mejia-Avila4, Jose Raul Molina5, Evelyn Aranda Cano5, Adriana Miguel-Alvarez5, Ismael Valenzuela5, Viridiana Del Río-Guerrero6, Paloma Rodriguez5, Mauricio Mora-Ramirez5, Nilda Espinola-Zavaleta4, Luis H Silveira-torre6, Angélica Vargas Guerrero7 and Laura A Martínez-Martínez8, 1Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 2BENEMERITA UNIVERSIDAD AUTONOMA DE PUEBLA, Mexico City, Mexico, 3INSTITUTO NACIONAL DE CARDIOLOGIA, Ciudad de México, Mexico, 4Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 5Instituto Nacional de Cardiologia, Mexico City, Mexico, 6Instituto Nacional de Cardiología, Mexico City, Mexico, 7Instituto Nacional de Cardiología, Mexico City, Mexico, 8Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

    Background/Purpose: Takayasu arteritis (TAK) is a chronic, granulomatous large-vessel vasculitis. As TAK has a chronic course, higher frequency rates of anxiety and depression are reported…
  • Abstract Number: 0702 • ACR Convergence 2023

    Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study

    Yanint Raksadawan, Sabahat Usmani, Harigopal Sandhyavenu, Thatiana Schulze Goni, Jalpan Patel, Hafiz Muhammad Waqar Younas and Amro Taha, Weiss Memorial Hospital, Chicago, IL

    Background/Purpose: Cardiac disease has been known to be a major morbidity and mortality cause in vasculitis. Large vessel vasculitis is mostly associated with pericarditis, myocarditis…
  • Abstract Number: 1648 • ACR Convergence 2023

    EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice: 2023 Update

    Christian Dejaco1, Sofia Ramiro2, Milena Bond3, Philipp Bosch4, Cristina Ponte5, Sarah Mackie6, Thorsten Bley7, Daniel Blockmans8, Sara Brolin9, Ertugrul Cagri Bolek10, Rebecca Cassie11, Maria C Cid12, Juan Molina-Collada13, Bhaskar Dasgupta14, Berit Dalsgaard Nielsen15, Eugenio De Miguel16, Haner Direskeneli17, Christina Duftner18, Alojzija Hocevar19, Anna Molto20, Valentin Sebastian Schäfer21, Luca Seitz22, Riemer H.J.A. Slart23 and Wolfgang Schmidt24, 1Azienda Sanitaria Alto Adige, Brunico, Italy, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Azienda sanitaria dell'Alto Adige, Merano, Italy, 4Medical University of Graz, Graz, Austria, 5Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 7Institute of Diagnostic and Interventional Radiology, University Hospital Würzburg, Würzburg, Germany, 8Department of General Internal Medicine, University Hospitals Leuven, Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium, 9Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden, 101-Hacettepe University Vasculitis Research Centre, Ankara, Turkey/ 2-Vasculitis Translational Research Program, NIAMS, NIH, US, Ankara, Turkey, 11n/a, Leicester, United Kingdom, 12Hospital Clinic Barcelona, Barcelona, Spain, 13Hospital General Universitario Gregorio Marañón, Madrid, Spain, 14Mid & South Essex University Hospitals NHS Foundation Trust; Southend University Hospital, Westcliff-on-sea, United Kingdom, 15Department of Internal Medicine, Horsens, Denmark, 16Hospital Universitario La Paz, Madrid, Spain, 17Division of Rheumatology, Medical School, Marmara University, Istanbul, Turkey, 18Medical University Innsbruck, Innsbruck, Austria, 19Department of Rheumatology, Universitiy Medical Centre Ljubljana, Ljubljana, Slovenia, 20HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 21Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, Bonn, Germany, 22Rheumatology and Immunology, Inselspital University Hospital Bern, Bern, Switzerland, 23University of Twente, Enschede, Netherlands, 24Rheumatology, Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany

    Background/Purpose: Imaging recommendations for primary large vessel vasculitis (LVV) were developed in 2018. Several new studies have emerged since then, and an update of the…
  • Abstract Number: 0706 • ACR Convergence 2023

    Aortitis and Periaortitis Spectrum in 135 Patients from a Single Referral Centre

    Fernando López1, Javier Loricera2, Carmen Secada3, Lucía García-Alcalde4, María Núñez-Savar4, Ander Ucelay-Aristi4 and Ricardo Blanco5, 1Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, 4Department of Cardiovascular Surgery, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Aortitis is the inflammation of the aortic wall, and can be idiopathic or associated with a cluster of infectious and non-infectious diseases (1-3). Periaortitis,…
  • Abstract Number: 1882 • ACR Convergence 2023

    Imaging in Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Literature Review Informing the 2023 Update of the EULAR Recommendations

    Philipp Bosch1, Milena Bond2, Christian Dejaco3, Cristina Ponte4, Sarah Mackie5, Louise Falzon6, Wolfgang Schmidt7 and Sofia Ramiro8, 1Medical University of Graz, Graz, Austria, 2Azienda sanitaria dell'Alto Adige, Merano, Italy, 3Department of Rheumatology, Medical University Graz, Graz, Austria; Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy, 4Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 6University of Sheffield, Sheffield, United Kingdom, 7Immanuel Krankenhaus Berlin, Berlin, Germany, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Since the development of the EULAR recommendations for the use of imaging in large vessel vasculitis (LVV) in 2017, new data has emerged in…
  • Abstract Number: 060 • 2023 Pediatric Rheumatology Symposium

    Are the Levels of Cytokines Good Biomarkers for Smoldering Disease Activity in Childhood-Takayasu Arteritis?

    Gleice Clemente1, Maria Teresa Terreri2, Bruno Gualano3, Clovis Silva4 and Alexandre Wagner De Souza1, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2UNIFESP, São Paulo, Brazil, 3Universidade de São Paulo, São Paulo, 4Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Biomarkers for disease activity in adult Takayasu arteritis (TA) have been studied exhaustively, but there are inconsistencies among the studies (1). Childhood-TA (c-TA) differs…
  • Abstract Number: 071 • 2023 Pediatric Rheumatology Symposium

    Clinical Manifestations and Management of Takayasu Arteritis: A Single Center Pediatric Cohort

    Ana Luiza Altaffer1, Alvaro Orjuela2 and Marietta De Guzman2, 1Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: Takayasu arteritis (TA) is a rare granulomatous vasculitis that affects large vessels, including the aorta, its major branches, and the pulmonary artery. Data on…
  • Abstract Number: L17 • ACR Convergence 2022

    Evaluating the Safety and Factors Associated with Treatment Cessation in Takayasu Arteritis

    Robert Maughan1, Andrew Porter1, Chanaka Dahanayake2, Claudia Ianonne1, Ritu Alapat1, Charis Pericleous1, Taryn Youngstein3 and Justin Mason1, 1Imperial College London, London, United Kingdom, 2Barts Health NHS Trust, London, United Kingdom, 3Imperial NHS Trust, London, United Kingdom

    Background/Purpose: Immunosuppression in Takayasu Arteritis (TA) reduces the risk of arterial damage and disease progression. However, long-term use of glucocorticoids (GC) and other immunosuppressants carries…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology